Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""interstitial lung disease"" wg kryterium: Temat


Tytuł:
Smoking-Related Interstitial Fibrosis and Smoker's Macrophages.
Autorzy:
Taniuchi N; Department of Pulmonary Medicine, Nippon Medical School Musashi Kosugi Hospital.
Saito Y; Department of Pulmonary Medicine, Nippon Medical School Musashi Kosugi Hospital.
Motoda N; Department of Diagnostic Pathology, Nippon Medical School Musashi Kosugi Hospital.
Seike M; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School.
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2024 Mar 09; Vol. 91 (1), pp. 20-27. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Smokers*
Lung Diseases, Interstitial*/diagnostic imaging
Lung Diseases, Interstitial*/etiology
Humans ; Macrophages ; Fibrosis ; Smoking/adverse effects ; Lung/pathology
Czasopismo naukowe
Tytuł:
ABCA3 Deficiency-Variant-Specific Response to Hydroxychloroquine.
Autorzy:
Yang X; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Forstner M; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Rapp CK; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Rothenaigner I; Research Unit Signaling and Translation, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.
Li Y; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.; Medical College, Chongqing University, Chongqing 400044, China.
Hadian K; Research Unit Signaling and Translation, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.
Griese M; Dr. von Haunersches Kinderspital, German Center for Lung Research, University of Munich, Lindwurmstr. 4a, 80337 Munich, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 03; Vol. 24 (9). Date of Electronic Publication: 2023 May 03.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxychloroquine*/pharmacology
Hydroxychloroquine*/therapeutic use
Lung Diseases, Interstitial*/drug therapy
Lung Diseases, Interstitial*/genetics
Child ; Humans ; Retrospective Studies ; ATP-Binding Cassette Transporters/genetics ; Lung ; Mutation
Czasopismo naukowe
Tytuł:
Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development.
Autorzy:
Jeong E; Department of Medicine, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Hong H; Yale College, Yale University, New Haven, CT 06520, USA.; Department of Clinical Pharmacology and Therapeutics, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Lee YA; Division of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.
Kim KS; Department of Medicine, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.; Department of Clinical Pharmacology and Therapeutics, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.; East-West Bone & Joint Disease Research Institute, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 26; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lung Diseases, Interstitial*/etiology
Arthritis, Rheumatoid*/drug therapy
Idiopathic Pulmonary Fibrosis*/drug therapy
Antirheumatic Agents*/therapeutic use
Humans ; Inflammation/drug therapy ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Nintedanib in systemic sclerosis treatment: a case report.
Autorzy:
Kudsi M; Department of Rheumatology, Faculty of Medicine, Damascus University, Al-Mazzeh, Damascus, Syria.
Tarcha R; Department of Rheumatology, Faculty of Medicine, Damascus University, Al-Mazzeh, Damascus, Syria. .
Khalayli N; Faculty of Medicine, Damascus University, Damascus, Syria.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Feb 23; Vol. 18 (1), pp. 110. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Diseases, Interstitial*/etiology
Scleroderma, Localized*
Scleroderma, Systemic*/complications
Scleroderma, Systemic*/drug therapy
Female ; Humans ; Middle Aged ; Indoles ; Kidney ; Antineoplastic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Autorzy:
Miyashita K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan. .
Furuhashi K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Nakatani E; Graduate School of Public Health, Shizuoka Graduate University of Public Health, 4-27-2 Kita Ando, Aoiku, 420-0881, Shizuoka, Japan.
Inoue Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Yasui H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Suzuki Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Karayama M; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Enomoto N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Fujisawa T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Inui N; Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Ojima T; Department of Community Health and Preventive Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Suda T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Feb 21; Vol. 25 (1), pp. 95. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*
COVID-19*/complications
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/epidemiology
Lung Diseases, Interstitial*/complications
Adult ; Humans ; Pandemics ; COVID-19 Vaccines ; SARS-CoV-2 ; Retrospective Studies
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Assessing the acceptability and feasibility of remote spirometric monitoring for rural patients with interstitial lung disease: a multimethod approach.
Autorzy:
Boente RD; Department of Medicine, Division of Pulmonary, Critical Care, Allergy, Sleep and Occupational Medicine, Indiana University School of Medicine, 1120 W. Michigan St, Gatch Hall, CL 290B, Indianapolis, IN, 46202, USA. .; Roudebush VA Medical Center, Center for Health Information and Communication, Indianapolis, IN, USA. .
Schacht S; Department of Medicine, Division of Pulmonary, Critical Care, Allergy, Sleep and Occupational Medicine, Indiana University School of Medicine, 1120 W. Michigan St, Gatch Hall, CL 290B, Indianapolis, IN, 46202, USA.
Borton R; PatientMpower, Dublin, Ireland.
Vincent J; PatientMpower, Dublin, Ireland.
Golzarri-Arroyo L; Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.
Rattray N; Roudebush VA Medical Center, Center for Health Information and Communication, Indianapolis, IN, USA.; Regenstrief Institute, Inc., Indianapolis, IN, USA.; Department of Medicine, Indiana School of Medicine, Indianapolis, IN, USA.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Feb 20; Vol. 25 (1), pp. 92. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Lung Diseases, Interstitial*/diagnosis
Humans ; Prospective Studies ; Feasibility Studies ; Spirometry
Czasopismo naukowe
Tytuł:
Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
Autorzy:
Huang C; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China.
Sun YG; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China.
Ma C; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China.
Jiao P; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China.
Wu QJ; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China.
Tian WX; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China.
Yu HB; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China.
Tong HF; Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Da Hua Road, Dongdan, Beijing, 100730, P.R. China. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Feb 08; Vol. 19 (1), pp. 72. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Lung Diseases, Interstitial*/complications
Lung Diseases, Interstitial*/diagnosis
Humans ; Male ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Female ; Retrospective Studies ; Blood Loss, Surgical ; Risk Factors ; Postoperative Complications/etiology ; Pneumonectomy/methods ; Treatment Outcome ; Prognosis
Czasopismo naukowe
Tytuł:
Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy.
Autorzy:
Kitahara Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Inoue Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan. .
Yasui H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Karayama M; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.; Department of Chemotherapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Suzuki Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Furuhashi K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Enomoto N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Fujisawa T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Funai K; First Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Honda T; Department of Dermatology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Misawa K; Department of Otorhinolaryngology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Miyake H; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Takeuchi H; Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Inui N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.; Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Suda T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Jan 10; Vol. 25 (1), pp. 25. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Antineoplastic Agents*/adverse effects
Lung Diseases, Interstitial*/chemically induced
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/epidemiology
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Docetaxel/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.
Autorzy:
Okaya T; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Kawasaki T; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Sato S; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba 260-8670, Japan.
Koyanagi Y; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Tatsumi K; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Hatano R; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Ohnuma K; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Morimoto C; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.
Kasuya Y; Department of Biomedical Science, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Hasegawa Y; Department of Applied Genomics, Kazusa DNA Research Institute, Chiba 292-0818, Japan.
Ohara O; Department of Applied Genomics, Kazusa DNA Research Institute, Chiba 292-0818, Japan.
Suzuki T; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba 260-8670, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 06; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Pulmonary*/chemically induced
Hypertension, Pulmonary*/genetics
Lung Diseases, Interstitial*/chemically induced
Lung Diseases, Interstitial*/genetics
Osteochondrodysplasias*
Humans ; Animals ; Mice ; Dipeptidyl Peptidase 4/genetics ; Phosphatidylinositol 3-Kinases ; Bleomycin/toxicity ; Mice, Knockout ; Transforming Growth Factor beta/genetics
SCR Disease Name:
Smith-McCort Dysplasia
Czasopismo naukowe
Tytuł:
Clinical features of macrophage activation syndrome in adult dermatomyositis: A single-center retrospective case-control study.
Autorzy:
Zhu D; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ying S; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yang C; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Li S; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Tang S; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun C; Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Fang H; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qiao J; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Jan; Vol. 12 (1), pp. e1141.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatomyositis*/complications
Dermatomyositis*/diagnosis
Macrophage Activation Syndrome*/diagnosis
Macrophage Activation Syndrome*/etiology
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/etiology
Adult ; Humans ; Retrospective Studies ; Case-Control Studies
Czasopismo naukowe
Tytuł:
Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases.
Autorzy:
Pulito-Cueto V; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.
Genre F; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.
López-Mejías R; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.
Mora-Cuesta VM; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Pneumology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Iturbe-Fernández D; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Pneumology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Portilla V; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Rheumatology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Sebastián Mora-Gil M; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.
Ocejo-Vinyals JG; Department of Immunology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Gualillo O; SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab. (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Santiago University Clinical Hospital, 15706 Santiago de Compostela, Spain.
Blanco R; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Rheumatology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Corrales A; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Rheumatology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Ferraz-Amaro I; Department of Rheumatology, Hospital Universitario de Canarias, 38320 Santa Cruz de Tenerife, Spain.
Castañeda S; Rheumatology Department, Hospital Universitario de la Princesa, IIS-Princesa, Cátedra UAM-ROCHE EPID Futuro, Universidad Autónoma de Madrid, 28006 Madrid, Spain.
Cifrián Martínez JM; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Pneumology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.; School of Medicine, Universidad de Cantabria, 39011 Santander, Spain.
Atienza-Mateo B; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Rheumatology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
Remuzgo-Martínez S; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.
González-Gay MÁ; Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Instituto de Investigación Marqués de Valdecilla, Avenida Cardenal Herrera Oria s/n, Lab. 201/202, 39011 Santander, Spain.; Rheumatology Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.; Department of Medicine and Psychiatry, Universidad de Cantabria, 39011 Santander, Spain.; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 09; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Diseases, Interstitial*/complications
Lung Diseases, Interstitial*/diagnosis
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/diagnosis
Autoimmune Diseases*/complications
Autoimmune Diseases*/diagnosis
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/diagnosis
Humans ; Endothelin-1 ; Biomarkers
Czasopismo naukowe
Tytuł:
Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases.
Autorzy:
Barril S; Respiratory Department, Institut de Recerca Biomèdica de Lleida (IRBLleida), Hospital Universitari Arnau de Vilanova-Santa María, Lleida, Spain.
Acebo P; Unidad de Terapias Farmacológicas, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Millan-Billi P; Respiratory Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB-Sant Pau, Barcelona, Spain.; Hospital Universitario Germans Trias I Pujol, Barcelona, Spain.
Luque A; Unidad de Endotelio Funcional, Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Sibila O; Respiratory Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB-Sant Pau, Barcelona, Spain.
Tarín C; R&D Department, Atrys Health, Barcelona, Spain.
Tazi A; R75006, INSERM U976 Human Immunology Pathophysiology and Immunotherapy (HIPI), Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.; National Reference Center for Histiocytoses, Department of Pulmonology, AP-HP, Hôpital Saint-Louis, Paris, France.
Castillo D; Respiratory Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB-Sant Pau, Barcelona, Spain. .
Hortelano S; Unidad de Terapias Farmacológicas, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Dec 18; Vol. 24 (1), pp. 320. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/etiology
Lung Diseases, Interstitial*/metabolism
Histiocytosis, Langerhans-Cell*/diagnosis
Histiocytosis, Langerhans-Cell*/pathology
Idiopathic Pulmonary Fibrosis*
Humans ; Bronchoalveolar Lavage Fluid ; Smoking/adverse effects ; Cytokines ; Immunoglobulins ; Chemokines
Czasopismo naukowe
Tytuł:
Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease.
Autorzy:
Nava-Quiroz KJ; HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan, Mexico City 14080, Mexico.; Programa de Doctorado en Ciencias Médicas Odontológicas y de la Salud, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
López-Flores LA; HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan, Mexico City 14080, Mexico.; Programa de Doctorado en Ciencias Médicas Odontológicas y de la Salud, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
Pérez-Rubio G; HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan, Mexico City 14080, Mexico.
Rojas-Serrano J; Rheumatology Clinic, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan, Mexico City 14080, Mexico.
Falfán-Valencia R; HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan, Mexico City 14080, Mexico.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Dec 13; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Arthritis, Rheumatoid*
Lung Diseases, Interstitial*/genetics
Humans ; Protein-Arginine Deiminases/genetics ; Protein-Arginine Deiminases/metabolism ; Proteins ; Chronic Disease
Czasopismo naukowe
Tytuł:
Quantification of diffuse parenchymal lung disease in non-small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis.
Autorzy:
An YC; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim JH; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.
Noh JM; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Yang KM; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Oh YJ; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.
Park SG; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Pyo HR; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee HY; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Dec; Vol. 14 (36), pp. 3530-3539. Date of Electronic Publication: 2023 Nov 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Radiation Pneumonitis*/etiology
Radiation Pneumonitis*/epidemiology
Lung Neoplasms*/drug therapy
Lung Diseases, Interstitial*/diagnostic imaging
Lung Diseases, Interstitial*/complications
Humans ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Analysis of characteristics related to interstitial lung disease or pulmonary hypertension in patients with dermatomyositis.
Autorzy:
Wang C; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.; Department of Anesthesiology, Kunming Medical University, Kunming, China.
Yang H; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.; Department of Clinical Medicine, Kunming Medical University, Kunming, China.
Li T; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Wen Y; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Yang H; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.; Department of Anesthesiology, Kunming Medical University, Kunming, China.
Tang W; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.; Department of Clinical Medicine, Kunming Medical University, Kunming, China.
Li L; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Sun S; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2023 Dec; Vol. 17 (12), pp. 1328-1340. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatomyositis*/complications
Hypertension, Pulmonary*/etiology
Hypertension, Pulmonary*/complications
Lung Diseases, Interstitial*/complications
Lung Diseases, Interstitial*/epidemiology
Humans ; Interleukin-10 ; Interleukin-17 ; Prognosis ; Retrospective Studies ; Interleukin-6 ; Autoantibodies ; Interferon-Induced Helicase, IFIH1 ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulin M
Czasopismo naukowe
Tytuł:
Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease.
Autorzy:
Hu M; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Shen C; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Zheng F; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Zhou Y; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Teng L; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Zheng R; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Hu B; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Wang C; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Lu M; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China.
Xu X; Department of Rheumatology Immunology & Allergy Medicine, The Children's Hospital, Zhejiang Univesity School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310003, PR China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Nov 16; Vol. 24 (1), pp. 286. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatomyositis*/diagnosis
Dermatomyositis*/epidemiology
Dermatomyositis*/complications
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/epidemiology
Lung Diseases, Interstitial*/complications
Humans ; Child ; Retrospective Studies ; Nomograms ; Prognosis
Czasopismo naukowe
Tytuł:
Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study.
Autorzy:
Hyun DG; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Han SJ; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ji W; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choi CM; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lee JC; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim HC; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (33), pp. 3323-3330. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/therapy
Lung Neoplasms*/drug therapy
Lung Diseases, Interstitial*/complications
Lung Diseases, Interstitial*/therapy
Humans ; Prognosis ; Retrospective Studies ; Disease Progression ; Risk Factors
Czasopismo naukowe
Tytuł:
Association of family sequence similarity gene 13A gene polymorphism and interstitial lung disease susceptibility: A systematic review and meta-analysis.
Autorzy:
Hu Y; National Center for Respiratory Medicine, Beijing, P.R. China.; National Clinical Research Center for Respiratory Diseases, Beijing, P.R. China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P.R. China.
Li Z; China-Japan Friendship Hospital, Beijing, P.R. China.; Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, P.R. China.
Ren Y; National Center for Respiratory Medicine, Beijing, P.R. China.; National Clinical Research Center for Respiratory Diseases, Beijing, P.R. China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P.R. China.
Dai H; National Center for Respiratory Medicine, Beijing, P.R. China.; National Clinical Research Center for Respiratory Diseases, Beijing, P.R. China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P.R. China.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2023 Nov; Vol. 11 (11), pp. e2279. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Lung Diseases, Interstitial*/genetics
Lung Diseases, Interstitial*/complications
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/genetics
Arthritis, Rheumatoid*
Silicosis*/complications
Humans ; Polymorphism, Genetic ; GTPase-Activating Proteins/genetics
Czasopismo naukowe
Tytuł:
Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
Autorzy:
Zhang D; Department of Rheumatology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Wang H; Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Zhou X; Department of Rheumatology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Yang J; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Liu Y; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Wang W; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Jiang P; Department of Rheumatology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Fan B; Department of Rheumatology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Nov; Vol. 11 (11), pp. e1085.
Typ publikacji:
Journal Article
MeSH Terms:
Amino Acyl-tRNA Synthetases*
Myositis*/epidemiology
Myositis*/diagnosis
Lung Diseases, Interstitial*/epidemiology
Lung Diseases, Interstitial*/diagnosis
Arthritis*
Humans ; Prognosis ; Retrospective Studies ; Autoantibodies
Czasopismo naukowe
Tytuł:
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.
Autorzy:
Wu J; Department of Rheumatology Immunology and Allergy, Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, 3333, Binsheng Road, Hangzhou, 310052, China.
Zhou Q; Life Sciences Institute, Zhejiang University, Hangzhou, China.
Zhou H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lu M; Department of Rheumatology Immunology and Allergy, Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, 3333, Binsheng Road, Hangzhou, 310052, China. .
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2023 Oct 26; Vol. 21 (1), pp. 131. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Azetidines*/therapeutic use
Lung Diseases, Interstitial*/etiology
Lung Diseases, Interstitial*/genetics
Vascular Diseases*/drug therapy
Adult ; Child, Preschool ; Female ; Humans ; Inflammation/drug therapy ; Janus Kinase 1/genetics ; Pyrazoles/therapeutic use ; Male
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies